PLUR
Pluri Inc. NASDAQ$3.38
Mkt Cap $27.6M
52w Low $2.82
17.0% of range
52w High $6.10
50d MA $3.39
200d MA $3.90
P/E (TTM)
-0.9x
EV/EBITDA
-2.7x
P/B
—
Debt/Equity
-5.0x
ROE
179.2%
P/FCF
-1.6x
RSI (14)
—
ATR (14)
—
Beta
0.72
50d MA
$3.39
200d MA
$3.90
Avg Volume
7.5K
About
Pluri Inc., a biotechnology company, focuses on the development of placenta-based cell therapy product candidates for the treatment of multiple inflammatory, muscle injuries, and hematologic conditions. The company develops placental expanded (PLX) based cell therapy products, including PLX-PAD that is in Phase III clinical trials for the muscle recovery after surgery for hip fracture; in Phase II…
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | 1M% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 12, 2026 | AMC | -0.65 | -0.71 | -9.2% | 3.55 | -2.5% | +0.3% | +4.5% | +3.4% | +3.7% | +3.1% | -7.3% | — |
| Nov 12, 2025 | AMC | -0.74 | -0.65 | +12.2% | 4.45 | +1.8% | -6.1% | -13.3% | -18.0% | -18.0% | -19.8% | -30.8% | — |
| Sep 17, 2025 | AMC | -0.65 | -2.62 | -303.1% | 4.70 | -1.5% | -4.3% | -2.1% | +0.2% | -1.1% | -4.9% | -9.6% | — |
| May 13, 2025 | AMC | -0.73 | -0.94 | -28.8% | 5.35 | +0.4% | -9.3% | -5.8% | -2.6% | -7.5% | -9.0% | -19.6% | — |
| Feb 11, 2025 | AMC | — | -0.53 | — | 4.33 | -0.7% | +0.9% | +3.5% | +6.7% | +3.7% | +4.2% | +7.9% | — |
| Nov 12, 2024 | AMC | — | -1.08 | — | 5.53 | +7.4% | +9.2% | -1.4% | -2.7% | -9.4% | -8.7% | -13.0% | — |
| Sep 18, 2024 | AMC | 0.16 | -2.98 | -1962.5% | 5.20 | +0.8% | +5.2% | +2.9% | +0.6% | +9.6% | +13.8% | -8.7% | — |
| May 9, 2024 | AMC | -0.24 | -1.01 | -320.8% | 5.96 | -5.0% | -2.3% | +4.4% | +8.7% | +2.2% | +5.2% | -7.6% | — |
| Feb 12, 2024 | AMC | — | -0.96 | — | 6.40 | -3.8% | -7.5% | -6.7% | -3.8% | +3.8% | -2.5% | +20.6% | — |
| Nov 13, 2023 | AMC | — | -0.96 | — | 5.14 | -3.5% | -1.9% | +1.2% | -1.9% | -6.2% | -12.6% | -14.4% | — |
Recent Filings
8-K · 1.01
!! High
Unknown — 8-K 1.01: Material Agreement
PLUR's new Chutzpah Holdings agreement could expand distribution or revenue, but investors need details on financial terms and strategic impact to assess whether this materially benefits shareholder value.
Mar 27
8-K · 8.01
!! High
Pluri Inc. -- 8-K 8.01: Material Event / Announcement
Pluri Inc. regained Nasdaq compliance after its market capitalization exceeded $35 million for ten consecutive business days, resolving a previous listing rule violation.
Mar 2
Data updated apr 26, 2026 8:02pm
· Source: massive.com